“…Transgenic rodent models overproducing human-sequence Aβ develop profuse senile plaques and cerebral amyloid-β angiopathy (CAA), but they do not have substantial, AD-like neuronal cell loss, neurofibrillary tangles, and/or profound memory impairment (Jucker, 2010,Morrissette, et al, 2009). Aged nonhuman primates naturally accumulate abundant multimeric, human-sequence Aβ in plaques and CAA (D'Angelo, et al, 2013,Elfenbein, et al, 2007,Gearing, et al, 1996,Gearing, et al, 1997,Geula, et al, 2002,Heuer, et al, 2012,Lemere, et al, 2004,Lemere, et al, 2008,Perez, et al, 2013,Selkoe, et al, 1987,Walker, et al, 1990), yet they appear to be resistant to other behavioral and pathologic features that define AD in humans (Finch and Austad, 2012,Finch and Austad, 2015,Heuer, et al, 2012,Walker and Cork, 1999). Similarly, dogs generate human-sequence Aβ and manifest senile plaques and CAA in old age, but they also do not exhibit all features of AD (Fast, et al, 2013,Head, 2013).…”